Evidence map›Paper›PMID 37779854›Full record

ArticleClinical kidney journal2023

Effect of roxadustat on intact and C-terminal FGF23 levels in patients undergoing peritoneal dialysis: a

Zi Wang, Xiao Xu, Di Song, Bin Yang, Ying Xu, Tiantian Ma, Zhikai Yang, Gang Fu, Jing Zhao, Jie Dong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical kidney journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zi WangRenal Division, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China.
Xiao XuRenal Division, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China.
Di SongRenal Division, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China.
Bin YangRenal Division, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China.
Ying XuRenal Division, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China.
Tiantian MaRenal Division, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China.
Zhikai YangRenal Division, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China.
Gang FuRenal Division, Department of Medicine, Beijing Haidian Hospital, Beijing, China.
Jing ZhaoRenal Division, Department of Medicine, Beijing Hospital of Traditional Chinese Medicine, Beijing, China.
Jie DongRenal Division, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37779854
PMCPMC10539215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.